Latest News and Press Releases
Want to stay updated on the latest news?
-
Primary Endpoints Demonstrate CTx-1301 Can be Taken With or Without Food CTx-1301 is Designed as a True, Entire Active-Day Treatment for ADHD KANSAS CITY, Kan., April 29, 2025 (GLOBE NEWSWIRE) --...
-
EBC is enhancing liquidity for five major stock indices, allowing investors to benefit from lower trading costs during a global market resurgence.
-
KANSAS CITY, Kan., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
-
CTx-1301 on track to file for Marketing Approval with FDA in 1H 2025 Increase of $10 Million in Stockholders’ Equity KANSAS CITY, Kan., May 08, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:...
-
VANCOUVER, British Columbia, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Westhaven Gold Corp. (TSX-V: WHN) is pleased to announce that it has arranged to issue, on a non-brokered private placement basis, up...
-
KANSAS CITY, Kan., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
-
KANSAS CITY, Kan., April 14, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
-
Trial On Track for 3Q 2023 Results Pivotal Phase 3 Trial in Pediatric/Adolescent Patients Planned to Begin Mid-2023 KANSAS CITY, Kan., April 04, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:...
-
NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) -- Dow Jones, publisher of The Wall Street Journal, Barron’s, MarketWatch and more, is undertaking a full agency review across its consumer brands and its...
-
JACKSONVILLE, Fla., Nov. 18, 2020 (GLOBE NEWSWIRE) -- CSX continues to build its reputation in sustainability, earning a place on the Dow Jones Sustainability Index (DJSI) North America for the 10th...